Replacement therapy of coagulation factor preparations: Antithrombin, FFR PPSB, FXIII, rFVIIa;Gerinnungsaktive therapeutika: Antithrombin, FFP, PPSB, FXIII, rFVIIa

Hamostaseologie

Volumn 25, Issue 2, 2005, Pages 209-212

  Scharrer, Inge ^a,b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Antithrombin; Fresh frozen plasma; FVIIa; FXIII

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 13; FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLOOD SUBSTITUTION; BLOOD TRANSFUSION; DISSEMINATED INTRAVASCULAR CLOTTING; REVIEW; THROMBOSIS; TREATMENT INDICATION;

EID: 19444385814     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1619653     Document Type: Review

References (33)

1. Al Douri M, Shafi T, Al Khudairi D et al. Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. Blood Coagul Fibrinolysis 2000, 11 (Suppl. 1): 121-7.
2. Ameri A, Stolte S. Correlation of activated clotting time (ACT) with rFVIIa infusion and clinical efficacy in a patient with Glanzmann Thrombasthenia and platelet alloantibodies. Thromb Haemost 2002, 87: 1084.
3. Beeck H, Hellstern P. In vitro characterization of solvent/detergent- treated human plasma and of quarantine fresh frozen plasma. Vox Sang 1998, 74 (Suppl. 1): 219-23.
4. Berntorp E. Recombinant FVIIa in the treatment of warfarin bleeding. Sem Thromb Hemost 2000, 26: 433-5.
5. th International Edition. New York: McGraw-Hill 1991, 1304-12.
6. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965, 13: 516-30.
7. Erhardtsen E. Ongoing NovoSeven® trials. Intensive Care Med, 2002, 28:248-55.
8. Fourrier F, Chopin C, Huart JJ et al. Double-blind placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 1993, 104: 882-8.
9. Friederich PW, Geerdink H, Keller TT et al. Novel application of recombinant factor VIIa: the effect of the administration of recombinant activated VII (NovoSeven) on perioperative blood loos in patients undergoing transabdominal retropubic prostatectomy: the PROSE study. Infus Ther Transfus Med 2001, 28: 112-3.
10. Gerotziafas GT, Zervas C, Gavrielidis G et al. Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening haemorrhage. Am J Hematol 2002, 69: 219-22.
11. Grossmann RE, Geisen U, Schwender S et al. Continuous infusion of recombinant factor VIIa (NovoSeven®) in the treatment of a patient with Type III von-Willebrand's disease and alloantibodies against von-Willebrand factor. Thromb Haemost 2000, 83: 633-4.
12. Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemostas 1997, 78: 1463-7.
13. Hedner U, Erhardtsen E. Potential role for rhF VIIa in transfusion medicine. Transfusion 2002, 42: 114-24.
14. Hellstern P, Beeck H, Fellhauer A et al. for the PCC Study Group. Factor VII and Activated-Factor-VII Content of Prothrombin Complex Concentrates. Vox Sang 1997, 73: 155-61.
15. Heuer L, Blumenberg D. Rekombinanter Faktor VIIa (NovoSeven®). Ein Überblick über aktuelle und mögliche zukünftige Indikationen. Anaesthesist 2002, 51: 388-99.
16. Jurlander B, Thim L, Klausen N et al. Recombinant activated factor VII (rhFVIIa): Characterisation, manufacturing and clinical development. Sem Thromb Haemostas 2001, 27: 373-83.
17. Kenet G, Walden R, Eldad A et al. Surgical intervention failed to stop life-threatening bleeding caused by injury complicated by severe coagulopathy. Administration of recombinant factor VIIa immediately corrected the coagulopathy and stopped bleeding. Lancet 1999, 345: 1879.
18. Klein H, Dodd RY, Czik WH et al. Current status of solvent/detergent- treated frozen plasma. Transfusion 1998, 38: 102-7.
19. Köhler M et al. Virusinaktiviertes Plasma. Infusionsther Transfusionsmed 1994, 21 (Suppl. 1): 73-6.
20. nd (1977) update. Thromb Haemost 1997, 77: 197-211.
21. Lucia JF, Aguilar C, Orna E et al. Successful outcome of a cirrhotic patient with postoperative haematuria treated with a single high dose of recombinant factor VIIa. Haemophilia 2001, 7: 600-2.
22. Monroe DM, Hoffmann M, Oliver JA et al. A possible mechanism of action of activated factor VII independent of tissue factor. Blood Coagul Fibrinol 1998, 9(Suppl. 1): 15-20.
23. Muszek L, Yee VC, Hevessy Z. Blood coagulation factor XIII: Structure and function. Thromb Res 19999, 94: 271-305.
24. Nijenhuis AVM, van Bergeijk L, Huijgens PC et al. Acquired factor XIII deficiency due to an inhibitor: a case report and review of the literature. Haematology 2004, 89: ECR 14.
25. O'Shaughnessy DF, Atterbury C, Bolton Maggs P et al. Guidelines for the use of fresh-frozen-plasma, cryoprecipitate and cryosupernatant. The British Society for Haematology 2004, 126: 11-28.
26. Oldenburg J, Hertfelder HJ, Brackmann HH et al. Eigenschaften und Indikationen von PPSB-Konzentraten unter besonderer Berücksichtigung der Qualitätssicherung sowie flankierender therapeutischer Maßnahmen. Infusionsther Transfusionsmed 1996, 23: 271-80.
27. Poon MC. Use of recombinant factor VIIa inhereditary bleeding disorders. Current Opin Hematol 2001, 8: 312-8.
28. Preston FE, Laidlaw ST, Sampson B et al. Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. Br J Haematol 2002, 116: 619-24.
29. Römisch J, Bonik K, Diehl KH et al. Vergleichende In-vitro-Untersuchung von drei Prothrombin-komplex-Konzentraten (PPSB). Med Welt 1997, 48: 205-11.
30. Rosenberg RD. Actions and interaction of anti-thrombin and heparin. N Engl J Med 1975, 292: 146-51.
31. Scharrer I on behalf of the German NovoSeven Study Group. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency. Haemophilia 1999, 5: 253-9.
32. Schregel W, Sträub H, Wölk G et al. Erfolgreiche Therapie einer Verbrauchskoagulopathie bei EPH-Gestose mit mehrfachem Organyersagen. Anaesth Intensivther Notfallmed 1984, 19: 201-3.
33. Sutor AH, Bruhn HD, Schreiber R et al. Thrombosen im Kindesalter. Hämostaseologie 1992, 12: 82-93.